Ingredients Categories

Sponsored Content

Uelzena publishes 2025 annual report and remains resilient in a volatile dairy market.

7 Jul 2026

Uelzen, 26 June 2026 - Uelzena continues to perform well in a volatile dairy market, prioritising stability and clear investment in the future. Uelzena Group closed 2025 on a stable footing despite a challenging dairy market, achieving solid financial results, record raw material volumes and continued investments in efficiency, sustainability and future competitiveness.

The Uelzena Group has continued to perform well in the 2025 financial year in an extremely strained dairy market. Despite significant price fluctuations for milk fat and continued pressure on the skimmed milk powder market, the company remained commercially stable and made targeted investments in its future.“The current conditions on the dairy market are more challenging than ever and are expected to stay this way for the foreseeable future. This makes it all the more important to ensure stability and consistently develop our cooperative,” says Jörn Dwehus, Chairman of the Board.

Record raw material volume coupled with growing market pressureA volume of 844 million kg in supplied dairy ingredients was recorded in 2025, which included 757 million kg of unprocessed milk, making it the highest value the Uelzena Group has seen in its company’s history. The raw material base therefore performed well. Behind these figures were, in particular, good feed quality, favourable weather conditions, and efficiency improvements in milk production. At the same time, the high availability of raw materials was met with an increasingly challenging market environment. Particularly in the second half of the year, declining prices for milk fat and the continuing strained market situation in the skimmed milk powder segment led to noticeable pressure on processing. Despite the difficult market in the second half of 2025, the average milk payout of 48.67 euro cents per kg raw milk was above the payout in the previous year of 47.34 euro cents per kg.

Uelzena publishes 2025 annual report and remains resilient in a volatile dairy market.
Jörn Dwehus, Chairman of the Board, presents the figures for Uelzena Group’s 2025 financial year at the General Meeting on 26 June 2026.

Robust KPIs and continued investment in the futureThe company’s commercial stability is reflected in the key performance figures: The Uelzena Group achieved revenue of approx. €1.077 billion and generated an annual net profit of about €9.46 million. The equity ratio was above 40 %. At the same time, the raw material supply reached a historic high, while pricing difficulties persisted on the relevant markets.In parallel, the company made targeted investments in strategic areas for the future. These included digitalising production and logistics and increasing the shareholding in BHI Biohealth International GmbH. In addition, establishing a corporate carbon footprint and validating climate targets according to the SBTi standard laid important foundations for a structured climate management system that will remain effective in the long term.“We are consciously investing in efficiency, in sustainability and innovations in our existing business areas, even in difficult market periods. This ensures our long-term competitiveness,” says Dwehus.In the product sector, the company particularly focused on establishing transparent and responsible supply chains and on preparing for rising regulatory requirements. Processes to implement the German Act on Corporate Due Diligence Obligations in Supply Chains and the EU Regulation on Deforestation-free Products were further developed and provided with the corresponding data and traceability structures. The company also systematically reviewed its packaging solutions for regulatory conformity and took the first steps towards substituting critical packaging materials.

Employees, efficiency and regional responsibility as stabilising factorsIn 2025, production was marked by energy efficiency, resource conservation and technical optimisation. Existing plants were strategically optimised, including improvements in ventilation, air-conditioning and heating at the Uelzen site. The company also carried out work on the infrastructure at various sites, for example, relating to condensate management, climate control and air drying. These measures opened up additional potential to save energy and CO₂.Digital systems were further upgraded to increase transparency of energy, water and wastewater data and to enable more efficient process management. Further optimisations are planned for the current financial year along with embedding climate protection more deeply in the corporate strategy. The Uelzena Group could also report continuity and development in human resources. There were further measures taken to secure skilled staff and develop qualification, including marketing towards trainees, collaborating with schools and internal development programmes. Turnover remained virtually constant and the average period of employment was 10.8 years.“Our employees are a key stabilising factor. Their dedication and expertise significantly contribute to our continued success even in difficult market periods,” says Dwehus.The close regional ties remain an integral part of the company strategy: 95 % of the supplied milk is produced regionally. Similarly, the majority of services and materials are sourced from the local region. The Group is also involved in events, sponsorship and promotes volunteer work. In terms of compliance, there were no breaches in the reporting year.

You can read more about the company’s development and on the topic of sustainability at Uelzena at www.uelzena.de/en/nachhaltigkeit.

 


Read More

Related news

A new standard for omega-3 experience

A new standard for omega-3 experience

13 Apr 2026

Omega-3 quality is no longer just about purity or concentration. Senses™ by Naturmega delivers ultra-pure, sensory-optimised omega-3 with no taste, no odour, and improved stability.

Read more 
PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more